Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annan Yang

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Colloid and Interface Science|March 30, 2025
Versatile spiky spindle-shaped copper-based nanocomposites: A SERS substrate for discrimination, quantification and inactivation of multiple bacteriaZimin Gu, Tingting Chen, Duntao Zu, et al.
Journal of Pharmaceutical Analysis|February 26, 2025
Coupling of an Au@AgPt nanozyme array with an micrococcal nuclease-specific responsiveness strategy for colorimetric/SERS sensing of <i>Staphylococcus aureus</i> in patients with sepsisXueqin Huang, Yingqi Yang, Hanlin Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 10, 2024
Dual-Enhanced SERS Satellite Immuno-Nanocomplex for Multiple PSA-Mediated PHI Assay Toward Clinical Prostate Cancer ScreeningDong Chen, Yilin Ma, Annan Yang, et al.
Journal of Medicinal Chemistry|January 15, 2020
Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop CysteineGuangyan Du, Suman Rao, Deepak Gurbani, et al.
Chembiochem : a European Journal of Chemical Biology|April 23, 2023
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo ActivityEriko Koide, Mikaela L Mohardt, Zainab M Doctor, et al.
Gastroenterology|June 1, 2023
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination ChemotherapyLi Qiang, Megan T Hoffman, Lestat R Ali, et al.
Journal of Medicinal Chemistry|August 20, 2025
Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2Philip N Collier, Xiaozhang Zheng, Melissa Ford, et al.
Nature Chemical Biology|March 28, 2018
The dTAG system for immediate and target-specific protein degradationBehnam Nabet, Justin M Roberts, Dennis L Buckley, et al.
Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.
Cancer Discovery|May 17, 2019
Single and Dual Targeting of Mutant EGFR with an Allosteric InhibitorCiric To, Jaebong Jang, Ting Chen, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Colloid and Interface Science|March 30, 2025
Versatile spiky spindle-shaped copper-based nanocomposites: A SERS substrate for discrimination, quantification and inactivation of multiple bacteriaZimin Gu, Tingting Chen, Duntao Zu, et al.
Journal of Pharmaceutical Analysis|February 26, 2025
Coupling of an Au@AgPt nanozyme array with an micrococcal nuclease-specific responsiveness strategy for colorimetric/SERS sensing of <i>Staphylococcus aureus</i> in patients with sepsisXueqin Huang, Yingqi Yang, Hanlin Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 10, 2024
Dual-Enhanced SERS Satellite Immuno-Nanocomplex for Multiple PSA-Mediated PHI Assay Toward Clinical Prostate Cancer ScreeningDong Chen, Yilin Ma, Annan Yang, et al.
Journal of Medicinal Chemistry|January 15, 2020
Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop CysteineGuangyan Du, Suman Rao, Deepak Gurbani, et al.
Chembiochem : a European Journal of Chemical Biology|April 23, 2023
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo ActivityEriko Koide, Mikaela L Mohardt, Zainab M Doctor, et al.
Gastroenterology|June 1, 2023
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination ChemotherapyLi Qiang, Megan T Hoffman, Lestat R Ali, et al.
Journal of Medicinal Chemistry|August 20, 2025
Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2Philip N Collier, Xiaozhang Zheng, Melissa Ford, et al.
Nature Chemical Biology|March 28, 2018
The dTAG system for immediate and target-specific protein degradationBehnam Nabet, Justin M Roberts, Dennis L Buckley, et al.
Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.
Cancer Discovery|May 17, 2019
Single and Dual Targeting of Mutant EGFR with an Allosteric InhibitorCiric To, Jaebong Jang, Ting Chen, et al.
Pageof 4